2026-03-09 • Psychedelic Alpha

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

AtaiBeckley is in structured discussions with pharma companies and royalty investors about a potential partnership for its lead candidate, intranasal 5-MeO-DMT (BPL-003) for treatment-resistant depression (TRD), sources close to the company told Psychedelic Alpha. Here, we take a closer look...

External link. We are not responsible for the content.

Read more ↗

More From Psychedelic Alpha

2026-03-11 • Psychedelic Alpha

Pα+ Psychedelic Bulletin #221: Helus Reports Murky Phase 2a Results; AtaiBeckley Says R-MDMA Met Safety Goal in SAD, Details Phase 3 Design for 5-MeO-DMT in TRD; Psilocybin for Smoking Cessation Study Published

Policy Round-Up: State Momentum, Congressional Signals, and Colorado’s Data Build-Out • RAND Survey: Americans Divi...

2026-03-06 • Psychedelic Alpha

Pα+ February 2026 Psychedelic Bill Roundup

A state-by-state and federal review of psychedelics-related bills introduced or advanced in February 2026, including ...

2026-03-03 • Psychedelic Alpha

The State of the Psychedelic Industry & Open Questions (Video)

In the third video of a three-part series, Psychedelic Alpha’s Josh Hardman takes a look at some broader open questio...

Latest News

2026-04-23 • Lucid News

Learning to Die Well: Inside a Psychedelic End‑of‑Life Retreat

What if learning how to die well is also how we learn to live? Inside a psychedelic end‑of‑life retreat rooted in the...

Research
2026-04-23 • Psychedelics Today

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Seeing What Is There is at the center of this conversation with journalist and author Erica Rex, who joins Joe Moore ...

2026-04-23 • MAPS

MAPS Celebrates 40 Years at a Defining Moment for Psychedelics

April 22, 2026 — Forty years ago, Rick Doblin, Ph.D., incorporated the Multidisciplinary Association for Psychedelic ...

2026-04-22 • Psychedelics Today

Why Ketamine Is Changing Psychiatry

Scott Shannon, MD argues that ketamine is doing more than relieving depression. It may be helping psychiatry move bey...

2026-04-22 • DoubleBlind Magazine

The Dark Side of Psychedelic Healing, According to Erica Rex (1)

A conversation on trauma, power, and the risks of trusting systems meant to heal [...] Read More... The post The Dark...

2026-04-22 • Chemical Collective

The Difficulty of Sincerity After Psychedelics

Psychedelic experiences often heighten one’s sense of authenticity and sincerity, but this can make ordinary social i...